1-11 of 11
Arjan Buijs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF inactivating Mutations in T Cell Acute Lymphoblastic Leukemia

Willem K. Smits, Carlo Vermeulen, Rico Hagelaar, Shunsuke Kimura, Eric Vroegindeweij, Jessica G.C.A.M. Buijs-Gladdines, Ellen Van De Geer, Marjon J.A.M. Verstegen, Erik Splinter, Simon V. van Reijmersdal, Arjan Buijs, Niels Galjart, Winfried Van Eyndhoven, Max Jan Van Min, Roland P Kuiper, Patrick Kemmeren, Charles G. Mullighan, Wouter De Laat, Jules P.P. Meijerink
Journal: Blood
Blood (2021) 138 (Supplement 1): 501.
https://doi.org/10.1182/blood-2021-152221
Published: 2021
Journal Articles

Paired Analyses of Diagnostic and Relapse Samples of MLL rearranged Infant Acute Lymphoblastic Leukemia Reveals Potential Therapy-Resistant Genomic Alterations

Arjan Buijs, PhD, Marian JPL Stevens-Kroef, PhD, Edwin Sonneveld, PhD, Lars T. van der Veken, PhD
Journal: Blood
Blood (2014) 124 (21): 5345.
https://doi.org/10.1182/blood.V124.21.5345.5345
Published: 2014
Journal Articles

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

Brief Report
Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, Hartmut Goldschmidt, Pieter Sonneveld
Journal: Blood
Blood (2013) 121 (4): 624–627.
https://doi.org/10.1182/blood-2012-06-438101
Published: 2013
Includes: Supplemental data
Journal Articles

Relation Between Cereblon Expression and Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Thalidomide

Annemiek Broyl, MD, Rowan Kuiper, BSc, Mark van Duin, PhD, Bronno van der Holt, PhD, Laila el Jarari, MSc, Uta Bertsch, MD, Sonja Zweegman, MD, PhD, Arjan Buijs, PhD, Dirk Hose, MD, PhD, Henk Lokhorst, MD, PhD, Hartmut Goldschmidt, MD, PhD, Pieter Sonneveld, MD
Journal: Blood
Blood (2012) 120 (21): 3973.
https://doi.org/10.1182/blood.V120.21.3973.3973
Published: 2012
Journal Articles

Novel Bone Marrow Failure Syndrome Due to a Deletion of the EVI1/Mecom Gene.

Lars T. van der Veken, PhD, Marc Bierings, Merel Maiburg, MD, Floris Groenendaal, MD, PhD, Andries C Bloem, PhD, Nine V. Knoers, MD, PhD, Arjan Buijs, PhD
Journal: Blood
Blood (2012) 120 (21): 2368.
https://doi.org/10.1182/blood.V120.21.2368.2368
Published: 2012
Journal Articles

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma

e-blood
Richard W. J. Groen, Willy A. Noort, Reinier A. Raymakers, Henk-Jan Prins, Linda Aalders, Frans M. Hofhuis, Petra Moerer, Jeroen F. van Velzen, Andries C. Bloem, Berris van Kessel, Henk Rozemuller, Ellen van Binsbergen, Arjan Buijs, Huipin Yuan, Joost D. de Bruijn, Michel de Weers, Paul W. H. I. Parren, Jan Jacob Schuringa, Henk M. Lokhorst, Tuna Mutis, Anton C. M. Martens
Journal: Blood
Blood (2012) 120 (3): e9–e16.
https://doi.org/10.1182/blood-2012-03-414920
Published: 2012
Includes: Supplemental data
Journal Articles

A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci

Arjan Buijs, PhD, Saskia van der Crabben, MD, PhD, Bert van der Zwaag, PhD, Ellen van Binsbergen, MSc, Martin Poot, PhD, Okke de Weerdt, Marielle van Gijn, PhD, H. Karel Nieuwenhuis, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4851.
https://doi.org/10.1182/blood.V116.21.4851.4851
Published: 2010
Journal Articles

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Clinical Trials & Observations
Annemiek Broyl, Dirk Hose, Henk Lokhorst, Yvonne de Knegt, Justine Peeters, Anna Jauch, Uta Bertsch, Arjan Buijs, Marian Stevens-Kroef, H. Berna Beverloo, Edo Vellenga, Sonja Zweegman, Marie-Josée Kersten, Bronno van der Holt, Laila el Jarari, George Mulligan, Hartmut Goldschmidt, Mark van Duin, Pieter Sonneveld
Journal: Blood
Blood (2010) 116 (14): 2543–2553.
https://doi.org/10.1182/blood-2009-12-261032
Published: 2010
Includes: Supplemental data
Journal Articles

Simultaneous Analysis of Multiple Chromosomal Aberrations in Chronic Lymphocytic Leukemia (CLL) by Multiplex Ligation-Dependent Probe Amplification (MLPA).

Marian J.P.L. Stevens-Kroef, PhD, Annet Simons, PhD, Michael Egmont Petersen, PhD, Hanneke Gorissen, MD, Yvonne Nanciu, MD, Arjan Buijs, PhD, Reinier Raymakers, PhD, Ad Geurts van Kessel, PhD
Journal: Blood
Blood (2006) 108 (11): 2329.
https://doi.org/10.1182/blood.V108.11.2329.2329
Published: 2006
Journal Articles

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies

Brief Report
Arjan Buijs, Pino Poddighe, Richard van Wijk, Wouter van Solinge, Eric Borst, Leo Verdonck, Anton Hagenbeek, Peter Pearson, Henk Lokhorst
Journal: Blood
Blood (2001) 98 (9): 2856–2858.
https://doi.org/10.1182/blood.V98.9.2856
Published: 2001
Journal Articles

Identification and characterization of a new human ETS-family transcription factor, TEL2 , that is expressed in hematopoietic tissues and can associate with TEL1/ETV6

Mark D. Potter, Arjan Buijs, Brent Kreider, Luc van Rompaey, Gerard C. Grosveld
Journal: Blood
Blood (2000) 95 (11): 3341–3348.
https://doi.org/10.1182/blood.V95.11.3341
Published: 2000